Matches in Wikidata for { <http://www.wikidata.org/entity/Q66038234> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66038234 description "clinical trial" @default.
- Q66038234 description "ensayu clínicu" @default.
- Q66038234 description "klinisch onderzoek" @default.
- Q66038234 description "клінічне випробування" @default.
- Q66038234 name "Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic" @default.
- Q66038234 name "Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic" @default.
- Q66038234 type Item @default.
- Q66038234 label "Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic" @default.
- Q66038234 label "Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic" @default.
- Q66038234 prefLabel "Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic" @default.
- Q66038234 prefLabel "Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic" @default.
- Q66038234 P1132 Q66038234-785E233E-CE33-4627-957D-720E982D3092 @default.
- Q66038234 P1476 Q66038234-7EFC1123-1B51-4F7D-854B-9232FB34AB4A @default.
- Q66038234 P17 Q66038234-590AAE77-B78F-411F-8466-8EC5E3DF005D @default.
- Q66038234 P2899 Q66038234-39DDC997-D460-413F-A6B9-7C35773CD8E2 @default.
- Q66038234 P3098 Q66038234-4384681B-BF22-4A42-9E42-78AC04192306 @default.
- Q66038234 P31 Q66038234-25ADCF22-EB84-445A-A370-C54191F99E63 @default.
- Q66038234 P4844 Q66038234-CD5A2562-37B2-4532-A064-69F448E4E29B @default.
- Q66038234 P580 Q66038234-3A8D8109-CDFE-408A-8A0F-846CD03EC3A0 @default.
- Q66038234 P582 Q66038234-3D7CA168-0128-4825-BBD1-04695B4687CB @default.
- Q66038234 P6099 Q66038234-953A5001-53E8-4832-8530-468719741883 @default.
- Q66038234 P8363 Q66038234-F46F1D69-E49F-4D93-B9CB-218AEBDF68CC @default.
- Q66038234 P1132 "+580" @default.
- Q66038234 P1476 "A Phase III Study of Paclitaxel Via Weekly 1 Hour Infusion Versus Standard 3 Hour Infusion Every 3 Weeks With Herceptin (Trastuzumab) (NSC #688097) in the Treatment of Patients With/Without HER-2/Neu-Overexpressing Metastatic Breast Cancer" @default.
- Q66038234 P17 Q30 @default.
- Q66038234 P2899 "+18" @default.
- Q66038234 P3098 "NCT00003440" @default.
- Q66038234 P31 Q30612 @default.
- Q66038234 P4844 Q423762 @default.
- Q66038234 P580 "1998-07-01T00:00:00Z" @default.
- Q66038234 P582 "2004-07-01T00:00:00Z" @default.
- Q66038234 P6099 Q42824827 @default.
- Q66038234 P8363 Q78089383 @default.